Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices

Bibliographic Details
Main Authors:	Ewen, Edward, Zhang, Zugui, Simon, Teresa A, Kolm, Paul, Liu, Xianchen, Weintraub, William S
Format:	Online
Language:	English
Published:	Dove Medical Press 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480279/

Similar Items

The use of warfarin in veterans with atrial fibrillation
by: Bravata, Dawn M, et al.
Published: (2004)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
by: Molteni, Mauro, et al.
Published: (2014)

The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden
by: Björholt, Ingela, et al.
Published: (2007)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
by: Simon, Teresa A., et al.
Published: (2016)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-01-01)

Patterns of Warfarin Use in Subgroups of Patients with Atrial Fibrillation: A Cross-Sectional Analysis of 430 General Practices in the United Kingdom
by: Mohammed, Mohammed A., et al.
Published: (2013)

Atrial Fibrillation Patterns and Risks of Subsequent Stroke, Heart Failure, or Death in the Community
by: Lubitz, Steven A., et al.
Published: (2013)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: de Padua Mansur, Antonio, et al.
Published: (2012)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
by: Hansen, Carolina Malta, et al.
Published: (2012)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
by: Lee, Soyon, et al.
Published: (2012)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi, Jiyoon C, et al.
Published: (2014)

Association of GGCX gene polymorphism with warfarin dose in atrial fibrillation population in Xinjiang
by: Kamali, Xiayizha, et al.
Published: (2013)

Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
by: Juma, Salima, et al.
Published: (2013)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
by: Wisløff, Torbjørn, et al.
Published: (2014)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2011-01-01)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
by: Benamer, Sufyan, et al.
Published: (2016)

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
by: Nelson, Winnie W., et al.
Published: (2015)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
by: Touchette, Daniel R., et al.
Published: (2008)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
by: Breithardt, Günter, et al.
Published: (2016)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
by: Yao, Xiaoxi, et al.
Published: (2016)

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
by: Azoulay, Laurent, et al.
Published: (2012)

Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data
by: Hallinen, Taru, et al.
Published: (2014)

Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes
by: Gallagher, Arlene M, et al.
Published: (2014)

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation
by: Nelson, Winnie W., et al.
Published: (2014)

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study
by: Wang, Shirley V, et al.
Published: (2016)

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017)

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Husna Zayadi
Published: (2017)

Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
by: Abelson, Mark
Published: (2013)

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
by: Michele Scarano, et al.
Published: (2017-04-01)

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
by: Reddy, Vivek Y., et al.
Published: (2016)

Quality of Life, Activity Impairment, and Healthcare Resource Utilization Associated with Atrial Fibrillation in the US National Health and Wellness Survey
by: Goren, Amir, et al.
Published: (2013)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
by: Mant, Jonathan WF, et al.
Published: (2003)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
by: Laliberté, François, et al.
Published: (2015)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
by: Laliberté, François, et al.
Published: (2015)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
by: Dallalzadeh, Liane O., et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Real-practice thromboprophylaxis in atrial fibrillation
by: Deambrosis Paola, et al.
Published: (2017-06-01)

Variation in practice patterns among specialties in the acute management of atrial fibrillation
by: Funk, Ashley M, et al.
Published: (2015)

Atrial fibrillation in a primary care practice: prevalence and management
by: Ceresne, Lance, et al.
Published: (2002)

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
by: Holmqvist, Fredrik, et al.
Published: (2015)